NEW YORK, Feb. 20, 2022 /PRNewswire/ — Pomerantz LLP notifies traders of eHealth, Inc. (NASDAQ: EHTH) (“eHealth” or the “Business”) of a pending lawsuit versus eHealth and selected of its officers.   The class motion, In re eHealth Inc. Securities Litigation, No. 4:20-cv-02395-JST (the “Class Action”), is pending in the United States District Court for the Northern District of California on behalf of a course consisting of all persons and entities other than Defendants that procured or otherwise acquired eHealth popular inventory in between April 26, 2018 and July 23, 2020, inclusive (the “Class” and the “Class Period of time”).  The Course Action pursues statements towards the Defendants less than the Securities Exchange Act of 1934 (the “Trade Act”).

If you are a shareholder who acquired eHealth stock during the Class Time period, you have right until March 18, 2022 to ask the Courtroom to appoint you as Lead Plaintiff for the course.  To explore this motion, get in touch with Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 7980. People who inquire by e-mail are encouraged to include things like their mailing deal with, phone range, and the amount of shares acquired. 

[Click here for information about joining the class action]

eHealth is a wellness insurance plan broker that focuses on providing Medicare-associated policies on behalf of personal insurers.  Its primary resource of earnings is commissions from marketing Medicare Advantage, Medicare Complement, and Medicare Element D prescription drug insurance policies. On January 1, 2018, eHealth adopted and implemented a new accounting typical for recognizing revenue.  This typical, referred to herein as Accounting Normal Codification 606 or ASC 606, permitted eHealth to acknowledge promptly the entirety of the commissions it envisioned to acquire in excess of the envisioned existence of the guidelines.  Although eHealth marketed yearly guidelines that could be cancelled at any time by the buyer, it assumed that its policies would be renewed for quite a few years. Therefore, for a lot of of eHealth’s Medicare-linked policies, it identified between three and 5 several years of commissions quickly upon the sale of the policy.

The Complaint in the Course Action alleges that the assumption that eHealth’s buyers would renew its procedures was unrealistic and opposite to eHealth’s modern practical experience of both cancellations and renewals.  Beginning in 2017, eHealth started soliciting Medicare consumers with tv advertising. Late-evening commercials boasting $ monthly program premiums successfully produced a surge in customers in a limited interval of time.  Between 2017 and 2018, the range of Medicare-relevant coverage programs submitted to eHealth by candidates grew by 39%.  These customers, on the other hand, were being notorious for cancelling their procedures in small intervals of time, leading to eHealth to practical experience sky-rocketing “member churn” ratios, i.e., the share of consumers who terminate their insurance policies within the 1st year.  Notwithstanding, eHealth was capable to present analysts and investors with report-placing earnings thanks to the actuality that it was able to understand a few- to 5-a long time of commission earnings for these policies upfront and immediately.

The Grievance even more alleges that Class customers were being materially harmed by eHealth’s false and deceptive statements.  As a immediate final result of Defendants’ materially wrong and misleading statements, eHealth’s inventory price tag artificially amplified from a relative continual price tag of about $15.32 for every share of frequent stock on March 19, 2018 to $136.32 prior to April 8, 2020.  It was on that working day that Muddy Waters Capital, a well-known and remarkably respected investigation business, published a report revealing eHealth’s accounting misconduct.  The report disclosed, amongst other factors, that eHealth’s “hugely aggressive accounting masks [] a considerably unprofitable small business,” “that the crucial driver of progress given that 2018 has been EHTH’s reliance on Direct Response tv promoting, which appeals to an unprofitable, superior churn enrollee,” “that EHTH’s persistence assumptions in its LTV product [under ASC 606] appear highly aggressive when compared to truth.”  Muddy Waters report also disclosed that eHealth’s money statements for 2019: (a) overstated revenue by $128 million (b) overstated running revenue by $263 million and (c) understated an working decline of -$181 million. The Muddy Waters report resulted in a sharp drop in the value of eHealth’s stock, plummeting to $103.20 per share.

Subsequently, on July 23, 2020, when eHealth declared its earnings effects for the next quarter of fiscal 2020, its stock price fell once more as the details contained in its announcement verified substantive areas of the “member churn” allegations beforehand asserted in the Muddy Waters report.  In reaction, eHealth’s inventory price declined from a closing rate of $114 for each share on July 23, 2020 to $79.17 for each share on July 24, 2020.

Pomerantz LLP, with places of work in New York, Chicago, Los Angeles, Paris, and Tel Aviv, is acknowledged as a person of the premier corporations in the parts of company, securities, and antitrust course litigation.  Founded by the late Abraham L. Pomerantz, recognised as the dean of the class action bar, Pomerantz pioneered the industry of securities course steps. Now, extra than 85 a long time later on, Pomerantz carries on in the tradition he established, combating for the rights of the victims of securities fraud, breaches of fiduciary duty, and company misconduct. The Company has recovered a lot of multimillion-greenback damages awards on behalf of course associates. See www.pomlaw.com.

Get hold of:

Robert S. Willoughby

Pomerantz LLP

[email protected] 

888-476-6529 ext. 7980

View primary content material to down load multimedia:https://www.prnewswire.com/news-releases/pomerantz-legislation-company-notifies-buyers-of-ehealth-inc-of-a-pending-lawsuit-and-guide-plaintiff-deadline-of-march-18-2022-301486185.html

Resource Pomerantz LLP